{
  "round": 3,
  "request": {
    "reason": "现有候选在安全性与机制连接性上表现欠佳，需引入更多不同机制的候选以提升多样性。",
    "n": 4
  },
  "prev_hypotheses": [
    "Eculizumab",
    "Ravulizumab",
    "Furosemide",
    "Angiotensin II receptor blockers",
    "Cyclosporine",
    "Plasmapheresis",
    "Complement inhibitors",
    "Steroids",
    "Mycophenolate mofetil",
    "Anticoagulants",
    "Dialysis",
    "Supportive care"
  ],
  "status": "regenerated",
  "generated_seeds": [
    "Eculizumab",
    "Ravulizumab",
    "Corticosteroids",
    "Mycophenolate mofetil",
    "Cyclophosphamide",
    "Thrombopoietin receptor agonists",
    "Plasmapheresis",
    "Anticoagulants",
    "Aspirin",
    "Sirolimus",
    "Rituximab",
    "Belatacept"
  ],
  "new_hypotheses": [
    "Eculizumab",
    "Ravulizumab",
    "Corticosteroids",
    "Mycophenolate mofetil",
    "Cyclophosphamide",
    "Thrombopoietin receptor agonists",
    "Plasmapheresis",
    "Anticoagulants",
    "Aspirin",
    "Sirolimus",
    "Rituximab",
    "Belatacept"
  ]
}